MCM6 and breast carcinoma: Further assays confirmed that MCM6 was crotonylated in breast cancer cells, with significantly elevated levels of MCM6‐Kcr observed following HU treatment and triggering cellular replication stress, leading to DNA damage, cell cycle arrest and suppression of breast cancer cell proliferation.